PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Electronic address: pand1@mskcc.org.\', \'Division of Cardiology, Department of Internal Medicine, Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York, USA.\', \'Institution of Healthcare Delivery Science, Tisch Cancer Institute, Department of Health Science and Policy at the Icahn School of Medicine at Mount Sinai, New York, New York, USA.\', \'Massachusetts Eye and Ear Infirmary, Department of Otolaryngology, Head and Neck Surgery, Boston, Massachusetts, USA.\', \'Icahn School of Medicine at Mount Sinai, New York, New York, USA.\', \'Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0147-9563(21)00175-810.1016/j.hrtlng.2021.04.010
?:doi
?:hasPublicationType
?:journal
  • Heart & lung : the journal of critical care
is ?:pmid of
?:pmid
?:pmid
  • 34090177
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Pre-hospital antiplatelet medication use on COVID-19 disease severity.
?:type

Metadata

Anon_0  
expand all